The stability of the gut, oral, and circulating microbiomes in living kidney donors: A 2 years prospective study.

Clinical TransplantationVolume 37, Issue 9 e15084 LETTER TO THE EDITOR The stability of the gut, oral, and circulating microbiomes in living kidney donors: A 2 years prospective study Ricardo Araujo, Corresponding Author Ricardo Araujo [email protected] orcid.org/0000-0001-7382-4834 Nephrology & Infectious Diseases R & D Group, i3S—Instituto de Investigação e Inovação em Saúde, INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal Correspondence Ricardo Araujo, Nephrology & Infectious Diseases R&D Group, i3S - Instituto de Investigação e Inovação em Saúde, R. Alfredo Allen 208, 4200-135 Porto, Portugal. Email: [email protected]Search for more papers by this authorAna Merino Ribas, Ana Merino Ribas Nephrology & Infectious Diseases R & D Group, i3S—Instituto de Investigação e Inovação em Saúde, INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal Nephrology Department, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain Universitat Autònoma de Barcelona, Barcelona, SpainSearch for more papers by this authorSusana Sampaio, Susana Sampaio Nephrology & Infectious Diseases R & D Group, i3S—Instituto de Investigação e Inovação em Saúde, INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal Nephrology Department, Centro Hospitalar Universitário de São João, Porto, PortugalSearch for more papers by this authorNádia Silva, Nádia Silva Nephrology Department, Centro Hospitalar Universitário de São João, Porto, PortugalSearch for more papers by this authorJoana Campos, Joana Campos Nephrology & Infectious Diseases R & D Group, i3S—Instituto de Investigação e Inovação em Saúde, INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, PortugalSearch for more papers by this authorManuel Pestana, Manuel Pestana Nephrology & Infectious Diseases R & D Group, i3S—Instituto de Investigação e Inovação em Saúde, INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal Nephrology Department, Centro Hospitalar Universitário de São João, Porto, Portugal Faculdade de Medicina, Universidade do Porto, Porto, PortugalSearch for more papers by this authorBenedita Sampaio Maia, Benedita Sampaio Maia Nephrology & Infectious Diseases R & D Group, i3S—Instituto de Investigação e Inovação em Saúde, INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal Faculdade de Medicina Dentária, Universidade do Porto, Porto, PortugalSearch for more papers by this author Ricardo Araujo, Corresponding Author Ricardo Araujo [email protected] orcid.org/0000-0001-7382-4834 Nephrology & Infectious Diseases R & D Group, i3S—Instituto de Investigação e Inovação em Saúde, INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal Correspondence Ricardo Araujo, Nephrology & Infectious Diseases R&D Group, i3S - Instituto de Investigação e Inovação em Saúde, R. Alfredo Allen 208, 4200-135 Porto, Portugal. Email: [email protected]Search for more papers by this authorAna Merino Ribas, Ana Merino Ribas Nephrology & Infectious Diseases R & D Group, i3S—Instituto de Investigação e Inovação em Saúde, INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal Nephrology Department, Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain Universitat Autònoma de Barcelona, Barcelona, SpainSearch for more papers by this authorSusana Sampaio, Susana Sampaio Nephrology & Infectious Diseases R & D Group, i3S—Instituto de Investigação e Inovação em Saúde, INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal Nephrology Department, Centro Hospitalar Universitário de São João, Porto, PortugalSearch for more papers by this authorNádia Silva, Nádia Silva Nephrology Department, Centro Hospitalar Universitário de São João, Porto, PortugalSearch for more papers by this authorJoana Campos, Joana Campos Nephrology & Infectious Diseases R & D Group, i3S—Instituto de Investigação e Inovação em Saúde, INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, PortugalSearch for more papers by this authorManuel Pestana, Manuel Pestana Nephrology & Infectious Diseases R & D Group, i3S—Instituto de Investigação e Inovação em Saúde, INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal Nephrology Department, Centro Hospitalar Universitário de São João, Porto, Portugal Faculdade de Medicina, Universidade do Porto, Porto, PortugalSearch for more papers by this authorBenedita Sampaio Maia, Benedita Sampaio Maia Nephrology & Infectious Diseases R & D Group, i3S—Instituto de Investigação e Inovação em Saúde, INEB—Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal Faculdade de Medicina Dentária, Universidade do Porto, Porto, PortugalSearch for more papers by this author First published: 01 August 2023 https://doi.org/10.1111/ctr.15084Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Lee JR, Muthukumar T, Dadhania D, et al. Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation. 2014; 98: 697-705. 2Sampaio S, Araujo R, Merino-Ribas A, et al. Blood, gut and oral microbiome in kidney transplant recipients. Ind J Nephrol. 2023. In press. 3Zaza G, Dalla Gassa A, Felis G, Granata S, Torriani S, Lupo A. Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: comparison between an everolimus- and a standard tacrolimus-based regimen. PLoS One. 2017; 12:e0178228. 4Frutos MÁ, Crespo M, de la Oliva Valentín M, et al. Living-donor kidney transplant: guidelines with updated evidence. Nefrologia. 2022; 42: 1-4. 5Lee JR, Magruder M, Zhang L, et al. Gut microbiota dysbiosis and diarrhea in kidney transplant recipients. Am J Transplant. 2019; 19: 488-500. 6Jie Z, Xia H, Zhong SL, et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun. 2017; 8: 845. 7Tang WHW, Bäckhed F, Landmesser U, Hazen SL. Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review. J Am Coll Cardiol. 2019; 73: 2089-2105. Volume37, Issue9September 2023e15084 ReferencesRelatedInformation